Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SAFESKIN -- Ignore unavailable to you. Want to Upgrade?

To: Zephod who wrote (380)	10/28/1998 9:09:00 PM
From: Ron Kline	Read Replies (1) \| Respond to of 828

I've seen this happen with many stocks in the market these days. Companies that come out with earnings that beat the street and they decide to pound them. My best performing stocks last year were Theragenics and Safeskin. Guess what, both continue to beat the street but they both took a tumble. My guess is that it's really a PE problem and nothing to do with fundamentals. If you look in past history with SFSK it did take a tumble a couple of years ago. What is interesting is within 6 months afterwards if came right back. I do think this is a great long term investment and if you are willing to wait out the markets "hot and cold" approach to investing you will be richly rewarded. Due to the technicals it probably will not lead the next market cycle, but with time this company will continue to outperform the market. I feel like I know, I bought at the IPO and was too impatient and gave up about $60,000 dollars in profits if I held.

To: Zephod who wrote (380)	10/29/1998 12:39:00 AM
From: Beltropolis Boy	Read Replies (1) \| Respond to of 828

Safeskin conference call transcript outstanding find -- thank you! personally, i'd much rather read than rub my ear raw. and save it for future reference ... i'm going over it just now. many moons ago on this here thread, someone hinted that SFSK would branch out to produce love gloves. could it be true? ----- Q Okay. And one last question. Given where you are with new products, your balance sheet, what are you guys thinking these days about additional acquisitions? MR. JAFFE: I think I should take additional acquisitions. I think that it's really going to depend upon the new production introductions. We are now looking to other products. We really have a lot of glove growth, but we're really starting to pursue other acquisitions that will complement our supply chain, our sales force, and our manufacturing, so that I'd expect, in the next, you know, year or two, to start adding other non-glove products to the fold. Q Other non-glove products? Is that what you said? MR. JAFFE: Yes. So I think next year is a big year of -- this year and next year is additional glove products. We have a couple of surgeon gloves, we have some synthetic, we have exam gloves. We have quite a few new products to introduce, to really broaden the lines, so that we will really have a full, broad base, where we can walk into customers, and say they could have a powder- free selection, a latex-free selection, and really get competitive, to convert over to powder-free. And I think that as that gets entrenched, and our team gets settled, then I'm looking for other things to put through the same pipeline. Q Can you give me any hints, without giving away to your competitors, or your potential targets? MR. JAFFE: Yes. That they will be opportune, -- (laughs) -- and strategically fit where we're going. Q Any ideas of the product, though? Like what kind of thing you're thinking about? MR. JAFFE; No. The only thing I'll tell you, is that I couldn't give you specifics other than it's something that we'd want to leverage either our manufacturing, our sales force -- MR. MORASH: And obviously disposable. MR. JAFFE: Yeah. We're in the disposable protection and related services products. So, it would be something that's disposable, that we could sell through our sales force.